# Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

> **NCT07353957** · PHASE2 · RECRUITING · sponsor: **Merus B.V.** · enrollment: 180 (estimated)

## Conditions studied

- Lung Cancer - Non Small Cell Squamous
- Lung Cancer - Non Small Cell Non-Squamous

## Interventions

- **COMBINATION_PRODUCT:** Petosemtamab + Pembrolizumab

## Key facts

- **NCT ID:** NCT07353957
- **Lead sponsor:** Merus B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-27
- **Primary completion:** 2028-05-31
- **Final completion:** 2031-02-27
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07353957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07353957, "Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07353957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*